TipRanks on MSN4h
Analysts Maintain Strong Buy Rating for OmniAb Stock (OABI) Despite Price Decline
OmniAb’s ($OABI) stock tumbled roughly 25% this week after financial results for Q4 reflected a mix of revenue growth ...
Is Protalix BioTherapeutics (PLX) The High Growth Low Debt Stock to Invest in Now?
We recently published a list of 12 High Growth Low Debt Stocks to Invest in Now. In this article, we are going to take a look ...
1 Stock Worth Buying Near Its 52-Week Low, According to Wall Street
Iovance Biotherapeutics (NASDAQ: IOVA) is a biotech company with an innovative approach to developing cancer medicines.
Buying These Dirt-Cheap Stocks Could Be a Brilliant Move
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...
Avantax Advisory Services Inc. Has $644,000 Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)
Avantax Advisory Services Inc. increased its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 5.7% ...
Veracyte (NASDAQ:VCYT) Now Covered by Craig Hallum
Analysts at Craig Hallum assumed coverage on shares of Veracyte (NASDAQ:VCYT – Get Free Report) in a note issued to investors ...
Unleased lab space. Plunging valuations. Layoffs. In Massachusetts, the biotech slump is taking its toll.
There’s been no shortage of either in recent weeks. Plunging valuations across the biotech sector were thrust into the ...